Akash Tewari
Stock Analyst at Jefferies
(0.67)
# 2377
Out of 5,347 analysts
67
Total ratings
38.89%
Success rate
0.40%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ARVN Arvinas | Downgrades: Hold | 52 10 | 7.18 | 39.28% | 3 | May 2, 2025 | |
BMY Bristol-Myers Squibb | Maintains: Buy | 70 68 | 48.3 | 40.79% | 4 | Apr 23, 2025 | |
BMRN Biomarin Pharmaceuti... | Initiates Coverage On: Outperform | 95 | 58.05 | 63.65% | 2 | Nov 15, 2024 | |
BNTX BioNTech | Upgrades: Buy | 96 150 | 95.8 | 56.58% | 3 | Sep 17, 2024 | |
RLAY Relay Therapeutics | Upgrades: Buy | 11 16 | 3 | 433.33% | 3 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 177 189 | 122.95 | 53.72% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 80 | 16.93 | 372.53% | 2 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 29 75 | 33.5 | 123.88% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 994 1015 | 737.72 | 37.59% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 42 50 | 30.61 | 63.35% | 5 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 37 75 | 36.64 | 104.69% | 4 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 31 | 15.25 | 103.28% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 935 937 | 489.92 | 91.26% | 4 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 12 | n/a | n/a | 2 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 38 39 | 23.46 | 66.24% | 2 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 49 18 | 5.93 | 203.54% | 2 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 497 513 | 572.87 | -10.45% | 2 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 3.1 | 480.65% | 1 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 125 | 76.83 | 62.7% | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 8 11 | 11.43 | -3.76% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 30 4 | 5.2 | -30.77% | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 17 | 1.06 | 1503.77% | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 6 4 | n/a | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 68 69 | n/a | n/a | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 75 | 31.01 | 141.86% | 2 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 151 | 275.03 | -45.1% | 1 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 28 | 43.05 | -34.96% | 2 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Hold | 180 | n/a | n/a | 2 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 107 | n/a | n/a | 1 | Mar 12, 2021 |